Bile Therapy
- Name
- Bile Therapy
- Accession Number
- DBCAT002535
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Ursodeoxycholic acid A bile acid used for the treatment of primary biliary cirrhosis (PBC). Cholic Acid A bile acid used for the treatment of bile acid synthesis disorders due to single enzyme defects and as an adjunctive treatment of peroxisomal disorders with disrupted liver function. Obeticholic acid A bile acid analog and farnesoid X receptor agonist used to treat primary biliary cholangitis in adult patients with inadequate clinical response or intolerance to UDCA. Chenodeoxycholic acid A bile acid used for the treatment of primary biliary cirrhosis. Hymecromone A coumarin derivative that lacks anticoagulant properties but possesses choleretic and biliary antispasmodic activity. N-methylnicotinamide N-methylnicotinamide is an experimental drug with no approved indication. Piprozolin Not Annotated Cyclobutyrol Not Annotated Maralixibat An ileal bile acid transporter inhibitor indicated to treat cholestatic pruritus in patients with Alagille syndrome. Odevixibat An ileal sodium/bile acid cotransporter inhibitor indicated in the treatment of pruritus in patients with progressive familial intrahepatic cholestasis. - Drugs & Drug Targets